WallStreetZenWallStreetZen
Analyst Ranking
Bottom 7%
#4252 out of 4565 analysts
Average Return
-24.38%
Win Rate
18%6 out of 34
Risk vs Reward
Poor
Good

Mason Carrico's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Castle Biosciences IncCSTL
+46.91%$13.28$19.51
2023-07-05 -
2024-04-25
Strong Buy
Natera IncNTRA
+38.30%$66.00$91.28
2024-01-29 -
2024-04-25
Strong Buy
Natera IncNTRA
+35.23%$67.50$91.28
2024-01-16 -
2024-04-25
Strong Buy
Natera IncNTRA
+33.60%$39.67$53.00
2022-04-24 -
2023-04-24
Strong Buy
Veracyte IncVCYT
+17.10%$19.01$22.26
2022-05-04 -
2023-05-04
Strong Buy

Mason Carrico Analyst Color

Get additional color on Mason Carrico's coverage of popular stocks

Mason Carrico's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Dermtech IncDMTK
4Hold$1.50+156.41%Reiterates
7 days ago
Oncocyte CorpOCX
2Hold$4.00+63.93%Reiterates
9 days ago
Caredx IncCDNA
7Strong Buy$15.00+98.41%Reiterates
9 days ago
Illumina IncILMN
3Strong Buy$170.00+40.44%Reiterates
16 days ago
Natera IncNTRA
3Strong Buy$78.00-14.55%Reiterates
3 months ago
Pacific Biosciences Of California IncPACB
1Strong Buy$11.00+697.10%Initiates Coverage On
4 months ago
Cytek Biosciences IncCTKB
1Strong Buy$9.00+59.86%Initiates Coverage On
4 months ago
Akoya Biosciences IncAKYA
4Strong Buy$9.00+135.60%Maintains
5 months ago
Veracyte IncVCYT
3Strong Buy$34.00+74.54%Reiterates
7 months ago
Castle Biosciences IncCSTL
5Strong Buy$37.00+89.65%Reiterates
10 months ago
10x Genomics IncTXG
3Strong Buy$65.00+141.64%Reiterates
a year ago
Myriad Genetics IncMYGN
3Hold$24.00+33.48%Reiterates
a year ago
Guardant Health IncGH
3Strong Buy$63.00N/AReiterates
a year ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.